10-Q Filing

STREAMEX CORP. CIK: 1530766 Q2 2021

Filing Information

Form Type	10-Q
Accession Number	`0001185185-21-001099`
Period End Date	20210630
Filing Date	20210811
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	biosig20210630_10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 80 Income Statement 72 Cash Flow Statement 68 Stockholders Equity 56

Balance Sheet 80 line items

Line Item	Tag	Value	Unit	Period
Cash	`Cash`	$15.50M	USD	Point-in-time
Cash	`Cash`	$28.27M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$199.00K	USD	Point-in-time
Inventory	`InventoryNet`	$731.05K	USD	Point-in-time
Inventory	`InventoryNet`	$768.32K	USD	Point-in-time
Prepaid expenses and vendor deposits	`PrepaidExpenseCurrent`	$515.00K	USD	Point-in-time
Prepaid expenses and vendor deposits	`PrepaidExpenseCurrent`	$301.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$29.34M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$16.95M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$289.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$388.00K	USD	Point-in-time
Right-to-use assets, net	`OperatingLeaseRightOfUseAsset`	$306.00K	USD	Point-in-time
Right-to-use assets, net	`OperatingLeaseRightOfUseAsset`	$217.90K	USD	Point-in-time
Right-to-use assets, net	`OperatingLeaseRightOfUseAsset`	$252.00K	USD	Point-in-time
Accounts payable and accrued expenses, related parties (in Dollars)	`AccountsPayableRelatedPartiesCurrent`	$317.00K	USD	Point-in-time
Accounts payable and accrued expenses, related parties (in Dollars)	`AccountsPayableRelatedPartiesCurrent`	$80.00K	USD	Point-in-time
Patents, net	`FiniteLivedIntangibleAssetsNet`	$346.00K	USD	Point-in-time
Patents, net	`FiniteLivedIntangibleAssetsNet`	$336.00K	USD	Point-in-time
Trademarks	`IndefiniteLivedTrademarks`	$1.00K	USD	Point-in-time
Trademarks	`IndefiniteLivedTrademarks`	$1.00K	USD	Point-in-time
Prepaid expenses, long term	`PrepaidExpenseNoncurrent`	$5.00K	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$102.00K	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$101.00K	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total assets	`Assets`	$18.03M	USD	Point-in-time
Total assets	`Assets`	$30.39M	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Accounts payable and accrued expenses, including $80 and $317 to related parties as of June 30, 2021 and December 31, 2020, respectively	`AccountsPayableAndAccruedLiabilitiesCurrent`	$4.72M	USD	Point-in-time
Accounts payable and accrued expenses, including $80 and $317 to related parties as of June 30, 2021 and December 31, 2020, respectively	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.03M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Deferred revenue, short term	`DeferredRevenueCurrent`	-	USD	Point-in-time
Deferred revenue, short term	`DeferredRevenueCurrent`	$32.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.76M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	32.21M	shares	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$73.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	32.21M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.76M	shares	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$77.00K	USD	Point-in-time
Lease liability, short term	`OperatingLeaseLiabilityCurrent`	$313.00K	USD	Point-in-time
Lease liability, short term	`OperatingLeaseLiabilityCurrent`	$247.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.38M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.11M	USD	Point-in-time
Deferred revenue, long term	`DeferredRevenueNoncurrent`	-	USD	Point-in-time
Deferred revenue, long term	`DeferredRevenueNoncurrent`	$21.00K	USD	Point-in-time
Lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	$1.00K	USD	Point-in-time
Lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	$1.00K	USD	Point-in-time
Total long term debt	`LiabilitiesNoncurrent`	$22.00K	USD	Point-in-time
Total long term debt	`LiabilitiesNoncurrent`	$1.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$5.11M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.40M	USD	Point-in-time
Series C 9% Convertible Preferred Stock, $0.001 par value, $1,000 stated value, authorized 4,200 shares, 105 shares issued and outstanding; liquidation preference of $105 as of June 30, 2021 and December 31, 2020	`TemporaryEquityCarryingAmountAttributableToParent`	$105.00K	USD	Point-in-time
Series C 9% Convertible Preferred Stock, $0.001 par value, $1,000 stated value, authorized 4,200 shares, 105 shares issued and outstanding; liquidation preference of $105 as of June 30, 2021 and December 31, 2020	`TemporaryEquityCarryingAmountAttributableToParent`	$105.00K	USD	Point-in-time
Preferred stock,	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock,	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, authorized 200,000,000 shares, 32,205,479 and 30,764,792 issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$32.00K	USD	Point-in-time
Common stock, $0.001 par value, authorized 200,000,000 shares, 32,205,479 and 30,764,792 issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$31.00K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$181.34M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$187.14M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-157.00M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-173.03M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$24.37M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$14.14M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$374.00K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$802.00K	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.66M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.17M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.85M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.52M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$20.46M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$36.01M	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$30.39M	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$18.03M	USD	Point-in-time

Income Statement 72 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	$325.00K	USD	2 Qtrs
Revenue	`Revenues`	$207.00K	USD	1 Quarter
Revenue	`Revenues`	-	USD	1 Quarter
Cost of goods sold	`CostOfRevenue`	$62.00K	USD	1 Quarter
Cost of goods sold	`CostOfRevenue`	-	USD	1 Quarter
Cost of goods sold	`CostOfRevenue`	$161.00K	USD	2 Qtrs
Gross profit	`GrossProfit`	$145.00K	USD	1 Quarter
Gross profit	`GrossProfit`	$164.00K	USD	2 Qtrs
Gross profit	`GrossProfit`	-	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$5.72M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$10.64M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.93M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.67M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$16.61M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$6.48M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$13.75M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$24.46M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$22.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$49.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$43.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$91.00K	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$16.77M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$22.35M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$8.20M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$35.15M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-35.15M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-22.35M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-8.05M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-16.61M	USD	2 Qtrs
Interest income, net	`InterestIncomeExpenseNet`	$1.00K	USD	2 Qtrs
Interest income, net	`InterestIncomeExpenseNet`	$43.00K	USD	2 Qtrs
Interest income, net	`InterestIncomeExpenseNet`	$3.00K	USD	1 Quarter
Loss on foreign currency translation	`ForeignCurrencyTransactionGainLossBeforeTax`	$-1.00K	USD	1 Quarter
Loss on foreign currency translation	`ForeignCurrencyTransactionGainLossBeforeTax`	$-1.00K	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-16.61M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-22.35M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-35.11M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-8.05M	USD	1 Quarter
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net loss	`ProfitLoss`	$-8.56M	USD	1 Quarter
Net loss	`ProfitLoss`	$-16.61M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-12.76M	USD	1 Quarter
Net loss	`ProfitLoss`	$-22.35M	USD	1 Quarter
Net loss	`ProfitLoss`	$-35.11M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-8.05M	USD	1 Quarter
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-4.59M	USD	2 Qtrs
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-350.00K	USD	1 Quarter
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-3.16M	USD	1 Quarter
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-590.00K	USD	2 Qtrs
Net loss attributable to BioSig Technologies, Inc.	`NetIncomeLoss`	$-7.70M	USD	1 Quarter
Net loss attributable to BioSig Technologies, Inc.	`NetIncomeLoss`	$-16.02M	USD	2 Qtrs
Net loss attributable to BioSig Technologies, Inc.	`NetIncomeLoss`	$-30.52M	USD	2 Qtrs
Net loss attributable to BioSig Technologies, Inc.	`NetIncomeLoss`	$-19.19M	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$5.00K	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$3.00K	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$2.00K	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$9.00K	USD	2 Qtrs
Preferred stock dividend	`DividendsPreferredStock`	$5.00K	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$5.00K	USD	2 Qtrs
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-16.02M	USD	2 Qtrs
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-7.70M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-19.19M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-30.53M	USD	2 Qtrs
Net loss per common share, basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.24	USD	1 Quarter
Net loss per common share, basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.72	USD	1 Quarter
Net loss per common share, basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-1.20	USD	2 Qtrs
Net loss per common share, basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.50	USD	2 Qtrs
Weighted average number of common shares outstanding, basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	26.54M	shares	1 Quarter
Weighted average number of common shares outstanding, basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	32.17M	shares	1 Quarter
Weighted average number of common shares outstanding, basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	31.88M	shares	2 Qtrs
Weighted average number of common shares outstanding, basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	25.46M	shares	2 Qtrs

Cash Flow Statement 68 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-8.56M	USD	1 Quarter
Net loss	`ProfitLoss`	$-16.61M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-12.76M	USD	1 Quarter
Net loss	`ProfitLoss`	$-22.35M	USD	1 Quarter
Net loss	`ProfitLoss`	$-35.11M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-8.05M	USD	1 Quarter
Depreciation	`DepreciationDepletionAndAmortization`	$43.00K	USD	2 Qtrs
Depreciation	`DepreciationDepletionAndAmortization`	$91.00K	USD	2 Qtrs
Depreciation	`DepreciationDepletionAndAmortization`	$49.00K	USD	1 Quarter
Depreciation	`DepreciationDepletionAndAmortization`	$22.00K	USD	1 Quarter
Amortization of right to use assets	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$60.88K	USD	Point-in-time
Amortization of right to use assets	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$227.00K	USD	2 Qtrs
Amortization of right to use assets	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$230.00K	USD	2 Qtrs
Equity based compensation	`AllocatedShareBasedCompensationExpense`	$4.31M	USD	2 Qtrs
Equity based compensation	`AllocatedShareBasedCompensationExpense`	$15.74M	USD	2 Qtrs
Change in fair value of modified options	`EquityFairValueAdjustment`	-	USD	2 Qtrs
Change in fair value of modified options	`EquityFairValueAdjustment`	$-321.00K	USD	2 Qtrs
Fair value of subsidiary stock issued to acquire research and development from Trek Therapeutics, PBC	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$3.17M	USD	2 Qtrs
Fair value of subsidiary stock issued to acquire research and development from Trek Therapeutics, PBC	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	2 Qtrs
Fair value of subsidiary stock issued to acquire research an development	`ShareBasedCompensation`	$1.30M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$199.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$222.00K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$-37.00K	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$770.00K	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$209.00K	USD	2 Qtrs
Payment of long term deposit	`IncreaseDecreaseInDeposits`	-	USD	2 Qtrs
Payment of long term deposit	`IncreaseDecreaseInDeposits`	$53.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.61M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.69M	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-242.00K	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-226.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-13.91M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-14.22M	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$28.00K	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$182.00K	USD	2 Qtrs
Net cash used in investing activity	`NetCashProvidedByUsedInInvestingActivities`	$-182.00K	USD	2 Qtrs
Net cash used in investing activity	`NetCashProvidedByUsedInInvestingActivities`	$-28.00K	USD	2 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$25.21M	USD	2 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Proceeds from sale subsidiary stock to non-controlling interest, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$10.59M	USD	2 Qtrs
Proceeds from sale subsidiary stock to non-controlling interest, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	2 Qtrs
Proceeds from sale of common stock under a At-the-market offering, net of issuance costs	`ProceedsFromOtherEquity`	-	USD	2 Qtrs
Proceeds from sale of common stock under a At-the-market offering, net of issuance costs	`ProceedsFromOtherEquity`	$1.30M	USD	2 Qtrs
Proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	$2.23M	USD	2 Qtrs
Proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	$28.00K	USD	2 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	2 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$1.03M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.33M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$39.07M	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$24.82M	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-12.76M	USD	2 Qtrs
Cash and cash equivalents, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$36.93M	USD	Point-in-time
Cash and cash equivalents, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$12.11M	USD	Point-in-time
Cash and cash equivalents, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$28.27M	USD	Point-in-time
Cash and cash equivalents, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$15.50M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashAndCashEquivalentsAtCarryingValue`	$36.93M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashAndCashEquivalentsAtCarryingValue`	$12.11M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashAndCashEquivalentsAtCarryingValue`	$28.27M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashAndCashEquivalentsAtCarryingValue`	$15.50M	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	-	USD	2 Qtrs
Cash paid during the period for interest	`InterestPaidNet`	-	USD	2 Qtrs
Cash paid during the period for income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Cash paid during the period for income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Dividend payable on preferred stock charged to additional paid in capital	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$9.00K	USD	2 Qtrs
Dividend payable on preferred stock charged to additional paid in capital	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$5.00K	USD	2 Qtrs
Record right-to-use assets and related lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$218.00K	USD	2 Qtrs
Record right-to-use assets and related lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	2 Qtrs

Stockholders Equity 56 line items

Line Item	Tag	Value	Unit	Period
Options, per share	`ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice`	$2.96	USD	2 Qtrs
Sale of common stock under At-the-market offering, transaction expenses (in Dollars)	`PaymentsOfStockIssuanceCosts`	$40.37K	USD	Point-in-time
Preferred Stock, per share	`PreferredStockRedemptionPricePerShare`	$50.00	USD	Point-in-time
Warrants, per share	`ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1`	$6.16	USD	Point-in-time
Warrants, per share	`ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1`	$3.68	USD	Point-in-time
Warrants, per share	`ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1`	$3.75	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.66M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.17M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.85M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.52M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$20.46M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$36.01M	USD	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	30.76M	shares	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	32.21M	shares	Point-in-time
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$108.00K	USD	1 Quarter
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$140.00K	USD	1 Quarter
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$1.78M	USD	1 Quarter
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$2.66M	USD	Annual
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$1.92M	USD	2 Qtrs
Common stock issued for services (in Shares)	`StockIssuedDuringPeriodSharesIssuedForServices`	658,868.00	shares	Annual
Common stock issued for services (in Shares)	`StockIssuedDuringPeriodSharesIssuedForServices`	443,640.00	shares	2 Qtrs
Change in fair value of modified options	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$321.00K	USD	1 Quarter
Change in fair value of modified options	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$111.40K	USD	Point-in-time
Common stock issued upon exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.23M	USD	1 Quarter
Common stock issued upon exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$28.00K	USD	1 Quarter
Common stock issued upon exercise of options (in Shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	9,375.00	shares	2 Qtrs
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$9.05M	USD	1 Quarter
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$1.30M	USD	Point-in-time
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$16.16M	USD	1 Quarter
Sale of common stock (in Shares)	`StockIssuedDuringPeriodSharesNewIssues`	251,720.00	shares	Point-in-time
Sale of subsidiary shares to non-controlling interest	`MinorityInterestPeriodIncreaseDecrease`	$10.59M	USD	1 Quarter
Fair value of subsidiary shares issued to acquire research and development	`StockIssuedDuringPeriodValuePurchaseOfAssets`	$1.30M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$742.00K	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$4.41M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$11.22M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.65M	USD	1 Quarter
Preferred Stock dividend	`DividendsPreferredStock`	$5.00K	USD	1 Quarter
Preferred Stock dividend	`DividendsPreferredStock`	$2.00K	USD	1 Quarter
Preferred Stock dividend	`DividendsPreferredStock`	$3.00K	USD	1 Quarter
Preferred Stock dividend	`DividendsPreferredStock`	$5.00K	USD	1 Quarter
Preferred Stock dividend	`DividendsPreferredStock`	$9.00K	USD	2 Qtrs
Preferred Stock dividend	`DividendsPreferredStock`	$5.00K	USD	2 Qtrs
Net loss	`ProfitLoss`	$-35.11M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-22.35M	USD	1 Quarter
Net loss	`ProfitLoss`	$-8.05M	USD	1 Quarter
Net loss	`ProfitLoss`	$-16.61M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-8.56M	USD	1 Quarter
Net loss	`ProfitLoss`	$-12.76M	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.66M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.17M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.85M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.52M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$20.46M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$36.01M	USD	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	32.21M	shares	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	30.76M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.